Ovarian cancer metastatic and Saliva discolouration - from FDA reports
There is no Saliva Discolouration reported by people with Ovarian Cancer Metastatic yet. We study people who have Saliva Discolouration and Ovarian Cancer Metastatic from FDA . Find out below who they are, other conditions they have and drugs they take.
What to expect?
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Aug, 22, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Saliva discolouration and Ovarian cancer metastatic?
Expand the study to include reports from both FDA and eHealthMeSaliva discolouration and Ovarian cancer metastatic from FDA and eHealthMe reports
Ovarian Cancer Metastatic
Ovarian cancer metastatic (cancer of ovary spreads to other organ or parts) can be treated by Carboplatin (latest reports from 1,150 Ovarian cancer metastatic patients)
Saliva discolouration (change in colour of saliva) has been reported by people with chronic obstructive pulmonary disease, high blood pressure, atrial fibrillation/flutter, parkinson's disease, asthma (latest reports from 120 Saliva discolouration patients).